{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:17:30Z","timestamp":1784636250895,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004590","name":"Helse Midt-Norge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.seizure.2021.04.015","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T02:08:13Z","timestamp":1618970893000},"page":"12-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Rash during lamotrigine treatment is not always drug hypersensitivity: A retrospective cohort study among children and adults"],"prefix":"10.1016","volume":"89","author":[{"given":"Maryam","family":"Shirzadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Saunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Reimers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eylert","family":"Brodtkorb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.seizure.2021.04.015_bib0001","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/clpt.2011.79","article-title":"Phenotype standardization for immune-mediated drug-induced skin injury","volume":"89","author":"Pirmohamed","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.seizure.2021.04.015_bib0002","first-page":"348","article-title":"Drug reactions. In: bologniam J","volume":"21","author":"Valeyrie-Allanore","year":"2018","journal-title":"Schaffer J, Cerroni L, eds. Dermatology"},{"issue":"7","key":"10.1016\/j.seizure.2021.04.015_bib0003","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine-associated rash: risk\/benefit considerations in adults and children","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2021.04.015_bib0004","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1528-1167.2007.01109.x","article-title":"Rash from antiepileptic drugs: influence by gender, age, and learning disability","volume":"48","author":"Alvestad","year":"2007","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.seizure.2021.04.015_bib0005","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1212\/01.wnl.0000187118.19221.e4","article-title":"Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures","volume":"65","author":"Biton","year":"2005","journal-title":"Neurology"},{"issue":"25","key":"10.1016\/j.seizure.2021.04.015_bib0006","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut study group","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.seizure.2021.04.015_bib0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/abd1806-4841.20175070","article-title":"Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials","volume":"92","author":"Bloom","year":"2017","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.seizure.2021.04.015_bib0008","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199818040-00004","article-title":"Safety review of adult clinical trial experience with lamotrigine","volume":"18","author":"Messenheimer","year":"1998","journal-title":"Drug Saf"},{"issue":"Suppl 5","key":"10.1016\/j.seizure.2021.04.015_bib0009","first-page":"S37","article-title":"Safety of lamotrigine","volume":"35","author":"Richens","year":"1994","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.seizure.2021.04.015_bib0010","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4088\/JCP.v63n1110","article-title":"Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management","volume":"63","author":"Calabrese","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.seizure.2021.04.015_bib0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/WNF.0b013e3182055c07","article-title":"Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications","volume":"34","author":"Seo","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.seizure.2021.04.015_bib0012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.seizure.2014.12.001","article-title":"Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis","volume":"25","author":"Wang","year":"2015","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.seizure.2021.04.015_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007711","article-title":"Safety of lamotrigine in paediatrics: a systematic review","volume":"5","author":"Egunsola","year":"2015","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.seizure.2021.04.015_bib0014","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1345\/aph.18422","article-title":"Factors influencing the incidence of lamotrigine-related skin rash","volume":"33","author":"Wong","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.seizure.2021.04.015_bib0015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1528-1157.1997.tb01252.x","article-title":"Safety of long-term lamotrigine in epilepsy","volume":"38","author":"Mackay","year":"1997","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2021.04.015_bib0016","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1528-1157.2000.tb00197.x","article-title":"Rash with lamotrigine: dosing guidelines","volume":"41","author":"Messenheimer","year":"2000","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2021.04.015_bib0017","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.seizure.2021.04.015_bib0018","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1528-1167.2006.00423.x","article-title":"Predictors of Lamotrigine-associated rash","volume":"47","author":"Hirsch","year":"2006","journal-title":"Epilepsia"},{"issue":"Suppl 5","key":"10.1016\/j.seizure.2021.04.015_bib0019","first-page":"S30","volume":"40","author":"Matsuo","year":"1999","journal-title":"Lamotrigine. Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2021.04.015_bib0020","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1017\/S0317167100034910","article-title":"Rash in adult and pediatric patients treated with lamotrigine","volume":"25","author":"Messenheimer","year":"1998","journal-title":"Can J Neurol Sci"},{"issue":"7","key":"10.1016\/j.seizure.2021.04.015_bib0021","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1346-8138.13430","article-title":"Severe cutaneous adverse drug reactions","volume":"43","author":"Chung","year":"2016","journal-title":"J Dermatol"},{"issue":"8","key":"10.1016\/j.seizure.2021.04.015_bib0022","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.seizure.2021.04.015_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1535-7511.2006.00089.x","article-title":"Current understanding of delayed anticonvulsant hypersensitivity reactions","volume":"6","author":"Krauss","year":"2006","journal-title":"Epilepsy Curr"},{"issue":"3","key":"10.1016\/j.seizure.2021.04.015_bib0024","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pharep.2014.11.009","article-title":"Antiepileptic drugs and adverse skin reactions: an update","volume":"67","author":"B\u0142aszczyk","year":"2015","journal-title":"Pharmacol Rep"},{"issue":"7","key":"10.1016\/j.seizure.2021.04.015_bib0025","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","article-title":"Idiosyncratic adverse reactions to antiepileptic drugs","volume":"48","author":"Zaccara","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.04.015_bib0026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eplepsyres.2015.09.011","article-title":"Do HLA-A markers predict skin-reactions from aromatic antiepileptic drugs in a Norwegian population? A case control study","volume":"118","author":"Shirzadi","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2021.04.015_bib0027","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.seizure.2016.12.015","article-title":"No association between non-bullous skin reactions from lamotrigine and heterozygosity of UGT1A4 genetic variants *2(P24T) or *3(L48V) in Norwegian patients","volume":"45","author":"Shirzadi","year":"2017","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2021.04.015_bib0028","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/dmpt-2016-0025","article-title":"An update on HLA alleles associated with adverse drug reactions","volume":"32","author":"Fricke-Galindo","year":"2017","journal-title":"Drug Metab Pers Ther"},{"issue":"6","key":"10.1016\/j.seizure.2021.04.015_bib0029","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/tan.13530","article-title":"HLA-associated antiepileptic drug-induced cutaneous adverse reactions","volume":"93","author":"Mullan","year":"2019","journal-title":"HLA"},{"issue":"10","key":"10.1016\/j.seizure.2021.04.015_bib0030","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"42","author":"Kwan","year":"2001","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2021.04.015_bib0031","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ajp.2010.09.002","article-title":"Toxic epidermal necrolysis after sun-exposure probably due to lamotrigine and chlorpromazine","volume":"3","author":"Huang","year":"2010","journal-title":"Asian J Psychiatr"},{"issue":"12","key":"10.1016\/j.seizure.2021.04.015_bib0032","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1176\/ajp.156.12.2015","article-title":"Lamotrigine-induced rash after sun exposure","volume":"156","author":"Bozikas","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"July","key":"10.1016\/j.seizure.2021.04.015_bib0033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2019.07.003","article-title":"Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting","volume":"72","author":"Fowler","year":"2019","journal-title":"Seizure"},{"issue":"12","key":"10.1016\/j.seizure.2021.04.015_bib0034","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.4088\/JCP.v65n1219b","article-title":"Two cases of acneiform eruption associated with lamotrigine","volume":"65","author":"Nielsen","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.seizure.2021.04.015_bib0035","unstructured":"WHO - Uppsala Monitoring Centre causality assessment criteria. https:\/\/www.who.int\/medicines\/areas\/quality_safety\/safety_efficacy\/WHOcausality_assessment.pdf?ua=1. Accessed August 20, 2020."},{"issue":"8","key":"10.1016\/j.seizure.2021.04.015_bib0036","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1212\/WNL.53.8.1724","article-title":"A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal pediatric partial seizure study group","volume":"53","author":"Duchowny","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.seizure.2021.04.015_bib0037","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200022040-00003","article-title":"The tolerability of lamotrigine in children","volume":"22","author":"Messenheimer","year":"2000","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.seizure.2021.04.015_bib0038","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2017-000039","article-title":"Retrospective review of paediatric case reports of Stevens-Johnson syndrome and toxic epidermal necrolysis with lamotrigine from an international pharmacovigilance database","volume":"1","author":"Egunsola","year":"2017","journal-title":"BMJ Paediatr Open"},{"issue":"2","key":"10.1016\/j.seizure.2021.04.015_bib0039","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1542\/peds.2006-0148","article-title":"Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures","volume":"118","author":"Trevathan","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.seizure.2021.04.015_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eplepsyres.2017.05.006","article-title":"Common allergies do not influence the prevalence of cutaneous hypersensitivity reactions to antiepileptic drugs","volume":"135","author":"Bosak","year":"2017","journal-title":"Epilepsy Res"},{"issue":"2\u20133","key":"10.1016\/j.seizure.2021.04.015_bib0041","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2008.04.003","article-title":"Cross-reactivity pattern of rash from current aromatic antiepileptic drugs","volume":"80","author":"Alvestad","year":"2008","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1016\/j.seizure.2021.04.015_bib0042","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaad.2018.06.061","article-title":"Drug-induced phototoxicity: a systematic review","volume":"79","author":"Ben","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.seizure.2021.04.015_bib0043","first-page":"1560","article-title":"Chapter 87, Photodermatologic disorders. In: bolognia J, Schaffer J","author":"Lim","year":"2018","journal-title":"Cerroni L, eds. Dermatology"},{"issue":"6","key":"10.1016\/j.seizure.2021.04.015_bib0044","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1751-1097.2009.00590.x","article-title":"Photochemical reactions involved in the phototoxicity of the anticonvulsant and antidepressant drug lamotrigine (Lamictal)","volume":"85","author":"Bilski","year":"2009","journal-title":"Photochem Photobiol"},{"issue":"2","key":"10.1016\/j.seizure.2021.04.015_bib0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clindermatol.2018.12.004","article-title":"The rash with maculopapules and fever in adults","volume":"37","author":"Muzumdar","year":"2019","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.seizure.2021.04.015_bib0046","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clindermatol.2018.12.005","article-title":"The rash with maculopapules and fever in children","volume":"37","author":"Muzumdar","year":"2019","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.seizure.2021.04.015_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.seizure.2021.04.015_bib0048","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1060028016669525","article-title":"Antibiotic-induced rash in patients with infectious mononucleosis","volume":"51","author":"Thompson","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.seizure.2021.04.015_bib0049","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.seizure.2021.04.015_bib0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2332\/allergolint.55.27","article-title":"Immune mechanisms in drug allergy","volume":"55","author":"Roujeau","year":"2006","journal-title":"Allergol Int"},{"issue":"5","key":"10.1016\/j.seizure.2021.04.015_bib0051","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/pai.13055","article-title":"Hypersensitivity reactions to antiepileptic drugs in children","volume":"30","author":"Atanaskovi\u0107-Markovi\u0107","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.seizure.2021.04.015_bib0052","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/seiz.2000.0394","article-title":"Successful re-introduction of lamotrigine after initial rash","volume":"9","author":"Besag","year":"2000","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2021.04.015_bib0053","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-0404.2005.00381.x","article-title":"Lamotrigine-induced rash\u2013worth a rechallenge","volume":"111","author":"P-Codrea Tigaran","year":"2005","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.seizure.2021.04.015_bib0054","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1059-1311(05)80082-2","article-title":"Rechallenge with lamotrigine after initial rash","volume":"4","author":"Tavernor","year":"1995","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2021.04.015_bib0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S1461145708009504","article-title":"Lamotrigine-associated rash: to rechallenge or not to rechallenge?","volume":"12","author":"Lorberg","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.seizure.2021.04.015_bib0056","first-page":"27","article-title":"Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature","volume":"7","author":"Aiken","year":"2010","journal-title":"Psychiatry (Edgmont)"},{"issue":"6","key":"10.1016\/j.seizure.2021.04.015_bib0057","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jaip.2018.02.018","article-title":"The frequency and clinical features of hypersensitivity reactions to antiepileptic drugs in children: a prospective study","volume":"6","author":"Guvenir","year":"2018","journal-title":"J allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.seizure.2021.04.015_bib0058","first-page":"299","article-title":"Pilar cortina FF. Anticonvulsant drug hypersensitivity","volume":"12","author":"Galindo","year":"2002","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"6","key":"10.1016\/j.seizure.2021.04.015_bib0059","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3476(95)70047-1","article-title":"Lamotrigine for the treatment of epilepsy in childhood","volume":"127","author":"Besag","year":"1995","journal-title":"J Pediatr"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121001321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121001321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:57:36Z","timestamp":1761011856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121001321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":59,"alternative-id":["S1059131121001321"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.04.015","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rash during lamotrigine treatment is not always drug hypersensitivity: A retrospective cohort study among children and adults","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}